Axogen, Inc.
↗Alachua, USA
Axogen is a global leader in the science, development, and commercialization of surgical solutions for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and healthcare providers to restore nerve function and improve quality of life for patients with peripheral nerve injuries.
Their portfolio includes products such as the Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, and Avive+ Soft Tissue Matrix. The company is focused on making peripheral nerve repair an expected standard of care, addressing traumatic injuries and surgical procedures that impact nerve function.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Medical Devices / Peripheral Nerve Repair
SIZE & FINANCIALS
Employees:201-500
Revenue:$225M
Founded:2002
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
STOCK
Exchange:NASDAQ
Ticker:AXGN
Market Cap:$1.79B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Human tissue grafts, Porcine ECM
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Axogen Corporation, Axogen Processing Corporation, Axogen Europe GmbH, Axogen Germany GmbH
Key Partnerships:Evergen (Distribution agreement for Axoguard products)
COMPETITION
Position:Leader
Competitors:Medtronic, Exactech, CryoLife, MiMedx
LEADERSHIP
Key Executives:
Michael Dale - President, Chief Executive Officer and Board Director
Lindsey Hartley - Chief Financial Officer
Marc Began - Executive Vice President and General Counsel
Board Members:Paul Thomas (Chairman)
LINKS
Website:axogeninc.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Axogen, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Axogen, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.